Performance of Urinary Clusterin as a Biomarker for Diagnosis of Early Diabetic Nephropathy in type 2 Diabetes
Fadel, N., Abd El-Sattar, E., Abdel Fattah Ouda, I., Taha Morsi, F. (2023). Performance of Urinary Clusterin as a Biomarker for Diagnosis of Early Diabetic Nephropathy in type 2 Diabetes. EKB Journal Management System, 15(15), 60-68. doi: 10.21608/muj.2023.234857.1147
Naglaa Hamed Fadel; Eman Mohamed Abd El-Sattar; Iman Mohamed Abdel Fattah Ouda; Fatima Al-Taher Taha Morsi. "Performance of Urinary Clusterin as a Biomarker for Diagnosis of Early Diabetic Nephropathy in type 2 Diabetes". EKB Journal Management System, 15, 15, 2023, 60-68. doi: 10.21608/muj.2023.234857.1147
Fadel, N., Abd El-Sattar, E., Abdel Fattah Ouda, I., Taha Morsi, F. (2023). 'Performance of Urinary Clusterin as a Biomarker for Diagnosis of Early Diabetic Nephropathy in type 2 Diabetes', EKB Journal Management System, 15(15), pp. 60-68. doi: 10.21608/muj.2023.234857.1147
Fadel, N., Abd El-Sattar, E., Abdel Fattah Ouda, I., Taha Morsi, F. Performance of Urinary Clusterin as a Biomarker for Diagnosis of Early Diabetic Nephropathy in type 2 Diabetes. EKB Journal Management System, 2023; 15(15): 60-68. doi: 10.21608/muj.2023.234857.1147

Performance of Urinary Clusterin as a Biomarker for Diagnosis of Early Diabetic Nephropathy in type 2 Diabetes

Medicine Updates
Volume 15, Issue 15, October 2023, Page 60-68  XML PDF (1.24 MB)
Document Type: Original Article
DOI: 10.21608/muj.2023.234857.1147
View on SCiNiTO View on SCiNiTO
Authors
Naglaa Hamed Fadel email orcid 1; Eman Mohamed Abd El-Sattar2; Iman Mohamed Abdel Fattah Oudaorcid 3; Fatima Al-Taher Taha Morsi4
1lecturer of endocrinology and diabetes, Department of Internal Medicine, Faculty of Medicine, Port Said University, Port Said, Egypt.
2Department of family medicine, faculty of Medicine, Zagazig University
3Lecturer of clinical pathology, Faculty of Medicine, Zagazig University
4lecturer of nephrology, Department of Internal Medicine, faculty of Medicine Zagazig University,
Abstract
Aims:
Diabetic kidney disease (DKD) is considered one of the rising issues nowadays due to the growing incidence of diabetes especially type 2. The use of variable novel biomarkers for early detection and correlation with DKD is a general direction in most of the current literature, so we aim to evaluate the diagnostic significance of urinary clusterin as an early marker of DKD and correlate its level with the traditional markers of DKD.
Methods:
An observational study included 90 subjects, 45 patients with type 2 diabetes (T2DM) and another 45 subjects without diabetes who were age, sex, and BMI matched. The group of diabetes was classified according to the level of albuminuria into 3 subgroups; normoalbuminuric, microalbumineric, and macroalbuminuric.
Results:
urinary clusterin was higher in the group with diabetes even in the absence of albuminuria compared to the control group with significantly higher levels of clusterin with the advancing of the albuminuric stage.
Conclusion:
Urinary clusterin is considered an early sensitive marker in predicting DKD in T2DM at a cutoff point of 16.9 ng/ml (Sensitivity 97.8%, specificity 97.8%), and its level showed a significant progression with the advancement of the stage of nephropathy.
Keywords
Keywords Clusterin; diabetic nephropathy; CKD marker; T2DM; albuminuria
Statistics
Article View: 192
PDF Download: 64